Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (18)

  1. Francesca De Cagna, Laura Fusar-Poli, Stefano Damiani, Matteo Rocchetti, Gianluca Giovanna, Alessia Mori, Pierluigi Politi, Natascia Brondino. The Role of Intranasal Oxytocin in Anxiety and Depressive Disorders: A Systematic Review of Randomized Controlled Trials. Clin Psychopharmacol Neurosci 2019;17:1
    https://doi.org/10.9758/cpn.2019.17.1.1
  2. Rebecca Harvey, Panoraia Andriopoulou, Sarah Grogan. Perceived mechanisms of change in therapeutic yoga targeting psychological distress. Journal of Bodywork and Movement Therapies 2020;24:274
    https://doi.org/10.1016/j.jbmt.2019.06.014
  3. F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva, F. Drago, Eliot H. Ohlstein. International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacol Rev 2018;70:475
    https://doi.org/10.1124/pr.117.014977
  4. Eugene Lin, Shih-Jen Tsai. Frontiers in Psychiatry. 2018.
    https://doi.org/10.1007/978-981-32-9721-0_7
  5. L. K. Khokhlov, N. E. Lukyanov. Pharmacogenetics of Antidepressants: from Genetic Findings to Predictive Strategies. Acta biomedica scientifica 2019;4:33
    https://doi.org/10.29413/ABS.2019-4.2.5
  6. Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Soo-Jung Lee, Tae-Youn Jun, Sheng-Min Wang, Ashwin A. Patkar, Prakash S. Masand, Changsu Han, Chi-Un Pae, Alessandro Serretti. Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1. Clin Psychopharmacol Neurosci 2019;17:364
    https://doi.org/10.9758/cpn.2019.17.3.364
  7. Lucie Bartova, Markus Dold, Alexander Kautzky, Chiara Fabbri, Marie Spies, Alessandro Serretti, Daniel Souery, Julien Mendlewicz, Joseph Zohar, Stuart Montgomery, Alexandra Schosser, Siegfried Kasper. Results of the European Group for the Study of Resistant Depression (GSRD) — basis for further research and clinical practice. The World Journal of Biological Psychiatry 2019;20:427
    https://doi.org/10.1080/15622975.2019.1635270
  8. S. Mas, P. Gassó, N. Rodríguez, B. Cabrera, G. Mezquida, A. Lobo, A. González‐Pinto, M. Parellada, I. Corripio, E. Vieta, J. Castro‐Fornieles, J. Bobes, J. Usall, J. Saiz‐Ruiz, F. Contreras, E. Parellada, M. Bernardo, Amalia Lafuente, Miquel Bioque, Covadonga M. Diaz‐Caneja, Javier González‐Peñas, Anna Alonso Solis, Mireia Rebella, Itxaso González‐Ortega, Ariadna Besga, Julio SanJuan, Juan Nacher, Laura Morro, Clara Montserrat, Esther Jimenez, Susana Gomes Da Costa, Immaculada Baeza, Elena de la Serna, S Rivas, C Diaz, Pilar A Saiz, Leticia Garcia‐Álvarez, Miguel Gutierrez Fraile, Arantzazu Zabala Rabadán, Iosune Torio, Roberto Rodríguez‐Jimenez, Anna Butjosa, Marta Pardo, Salvador Sarró, Edith Pomarol‐Clotet, Angela Ibañez Cuadrado, Manuel J Cuesta. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first‐episode psychosis cohort. Acta Psychiatr Scand 2019
    https://doi.org/10.1111/acps.13131
  9. In Hee Shim, Jonghun Lee, Moon‐Doo Kim, Young‐Eun Jung, Kyung Joon Min, Young‐Joon Kwon, Ji Sun Kim, Kwanghun Lee, Young Sup Woo, Beomwoo Nam, Jeong Seok Seo, Jung Goo Lee, Duk‐In Jon, Inki Sohn, Sung‐Yong Park, Bo‐Hyun Yoon, Won‐Myong Bahk. The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM‐5. Int J Methods Psychiatr Res 2019;28
    https://doi.org/10.1002/mpr.1773
  10. Alessandro Serretti. Brexpiprazole: a step forward for precision medicine in resistant depression. Expert Opinion on Pharmacotherapy 2018;19:1817
    https://doi.org/10.1080/14656566.2018.1528233
  11. Filippo Corponi, Chiara Fabbri, Alessandro Serretti. NeuroPsychopharmacotherapy. 2018.
    https://doi.org/10.1007/978-3-319-56015-1_29-1
  12. Helena Domin, Natalia Piergies, Ewa Pięta, Elżbieta Wyska, Bartłomiej Pochwat, Piotr Wlaź, Maria Śmiałowska, Czesława Paluszkiewicz, Bernadeta Szewczyk. Characterization of the Brain Penetrant Neuropeptide Y Y2 Receptor Antagonist SF-11. ACS Chem. Neurosci. 2019;10:3454
    https://doi.org/10.1021/acschemneuro.9b00082
  13. Amanda E. Lyall, Martha E. Shenton, Marek Kubicki. Neuroimaging in Schizophrenia. 2019.
    https://doi.org/10.1007/978-3-030-35206-6_22
  14. Eleni Pitsillou, Sarah M. Bresnehan, Evan A. Kagarakis, Stevano J. Wijoyo, Julia Liang, Andrew Hung, Tom C. Karagiannis. The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression. Mol Biol Rep 2020;47:753
    https://doi.org/10.1007/s11033-019-05129-3
  15. Eugene Lin, Chieh-Hsin Lin, Hsien-Yuan Lane. Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches. IJMS 2020;21:969
    https://doi.org/10.3390/ijms21030969
  16. Mohamed S. Zulfarina, Syed-Badrul Syarifah-Noratiqah, Shuid A. Nazrun, Razinah Sharif, Isa Naina-Mohamed. Pharmacological Therapy in Panic Disorder: Current Guidelines and Novel Drugs Discovery for Treatment-resistant Patient. Clin Psychopharmacol Neurosci 2019;17:145
    https://doi.org/10.9758/cpn.2019.17.2.145
  17. Merrie J. Kaas. Will We Be Ready? Preparing Psychiatric-Mental Health Nurses for Future Practice. J Am Psychiatr Nurses Assoc 2020;26:112
    https://doi.org/10.1177/1078390319878767
  18. Chiara Fabbri, Alessandro Serretti. Genetics of Treatment Outcomes in Major Depressive Disorder: Present and Future. Clin Psychopharmacol Neurosci 2020;18:1
    https://doi.org/10.9758/cpn.2020.18.1.1